TC BioPharm announced that it has received a patent grant from European Patent Office covering the use of modified gamma delta cells for the treatment of cancer and viral indications. “The company intends to proceed with the patent process in specific European countries in line with the commercial strategy of TCBP,” the company stated.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCBP: